Estrogen receptor β: Switching to a new partner and escaping from estrogen

Science Signaling

Volumn 4, Issue 168, 2011, Pages

  Leung, Yuet Kin ^a,b   Ho, Shuk Mei ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR BETA; FULVESTRANT; KRUPPEL LIKE FACTOR 5; TRANSCRIPTION FACTOR FKHR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; KLF5 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR;

APOPTOSIS; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; DNA BINDING; DRUG EFFICACY; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ARTICLE; BIOLOGICAL MODEL; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROSTATE TUMOR; PROTEIN BINDING;

PYRONIA TITHONUS;

CELL PROLIFERATION; ESTRADIOL; ESTROGEN RECEPTOR BETA; ESTROGENS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MODELS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN BINDING; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 79954452703     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2001991     Document Type: Review

References (33)

1. E. V. Jensen, E. R. Desombre, T. Kawashima, T. Suzuki, K. Kyser, P. W. Jungblut, Estrogen-binding substances of target tissues. Science 158, 529-530 (1967)
2. G. G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, J. A. Gustafsson, Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93, 5925-5930 (1996)
3. J. M. Hall, D. P. McDonnell, Coregulators in nuclear estrogen receptor action: From concept to therapeutic targeting. Mol. Interv. 5, 343-357 (2005)
4. C. M. Klinge, S. C. Jernigan, K. A. Mattingly, K. E. Risinger, J. Zhang, Estrogen response elementdependent regulation of transcriptional activation of estrogen receptors α and β by coactivators and corepressors. J. Mol. Endocrinol. 33, 387-410 (2004)
5. C. Zhao, K. Dahlman-Wright, J. A. Gustafsson, Estrogen receptor β: An overview and update. Nucl. Recept. Signal. 6, e003 (2008)
6. J. Matthews, B. Wihlén, M. Tujague, J. Wan, A. Ström, J. A. Gustafsson, Estrogen receptor (ER) β modulates ERα-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol. Endocrinol. 20, 534-543 (2006)
7. Z. Papoutsi, C. Zhao, M. Putnik, J. A. Gustafsson, K. Dahlman-Wright, Binding of estrogen receptor α/β heterodimers to chromatin in MCF-7 cells. J. Mol. Endocrinol. 43, 65-72 (2009)
8. X. Zhu, I. Leav, Y. K. Leung, M. Wu, Q. Liu, Y. Gao, J. E. McNeal, S. M. Ho, Dynamic regulation of estrogen receptor-β expression by DNA methylation during prostate cancer development and metastasis. Am. J. Pathol. 164, 2003-2012 (2004)
9. Z. Weihua, S. Makela, L. C. Andersson, S. Salmi, S. Saji, J. I. Webster, E. V. Jensen, S. Nilsson, M. Warner, J. A. Gustafsson, A role for estrogen receptor β in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 98, 6330-6335 (2001)
10. A. Morani, M. Warner, J. A. Gustafsson, Biological functions and clinical implications of oestrogen receptors α and β in epithelial tissues. J. Intern. Med. 264, 128-142 (2008)
11. G. Poelzl, Y. Kasai, N. Mochizuki, P. W. Shaul, M. Brown, M. E. Mendelsohn, Specific association of estrogen receptor β with the cell cycle spindle assembly checkpoint protein, MAD2. Proc. Natl. Acad. Sci. U.S.A. 97, 2836-2839 (2000)
12. V. Guerini, D. Sau, E. Scaccianoce, P. Rusmini, P. Ciana, A. Maggi, P. G. Martini, B. S. Katzenellenbogen, L. Martini, M. Motta, A. Poletti, The androgen derivative 5α-androstane-3β,17β-diol inhibits prostate cancer cell migration through activation of the estrogen receptor β subtype. Cancer Res. 65, 5445-5453 (2005)
13. Y. K. Leung, H. M. Lam, S. Wu, D. Song, L. Levin, L. Cheng, C. L. Wu, S. M. Ho, Estrogen recep- tor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocr. Relat. Cancer 17, 675-689 (2010)
14. P. Mak, I. Leav, B. Pursell, D. Bae, X. Yang, C. A. Taglienti, L. M. Gouvin, V. M. Sharma, A. M. Mercurio, ERβ impedes prostate cancer EMT by destabilizing HIF-1α and inhibiting VEGF-mediated snail nuclear localization: Implications for Gleason grading. Cancer Cell 17, 319-332 (2010)
15. S. Rohrmann, W. G. Nelson, N. Rifai, T. R. Brown, A. Dobs, N. Kanarek, J. D. Yager, E. A. Platz, Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J. Clin. Endocrinol. Metab. 92, 2519-2525 (2007)
16. S. M. Ho, Y. K. Leung, I. Chung, Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Ann. N.Y. Acad. Sci. 1089, 177-193 (2006)
17. A. Vermeulen, R. Rubens, L. Verdonck, Testosterone secretion and metabolism in male senescence. J. Clin. Endocrinol. Metab. 34, 730-735 (1972)
18. M. Krieg, R. Nass, S. Tunn, Effect of aging on endogenous level of 5α-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J. Clin. Endocrinol. Metab. 77, 375-381 (1993)
19. S.-M. Ho, W.-Y. Tang, J. Belmonte de Frausto, G. S. Prins, Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 66, 5624-5632 (2006)
20. I. Leav, S. M. Ho, P. Ofner, F. B. Merk, P. W. Kwan, D. Damassa, Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J. Natl. Cancer Inst. 80, 1045-1053 (1988)
21. G. S. Prins, L. Birch, W. Y. Tang, S. M. Ho, Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod. Toxicol. 23, 374-382 (2007)
22. G. S. Prins, K. S. Korach, The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73, 233-244 (2008)
23. Y. Nakajima, K. Akaogi, T. Suzuki, A. Osakabe, C. Yamaguchi, N. Sunahara, J. Ishida, K. Kako, S. Ogawa, T. Fujimura, Y. Homma, A. Fukamizu, A. Murayama, K. Kimura, S. Inoue, J. Yanagisawa, Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5. Sci. Signal. 4, ra22 (2011)
24. M. M. Ivanova, W. Mazhawidza, S. M. Dougherty, C. M. Klinge, Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells. Am. J. Respir. Cell Mol. Biol. 42, 320-330 (2010)
25. L. C. Sheldahl, R. A. Shapiro, D. N. Bryant, I. P. Koerner, D. M. Dorsa, Estrogen induces rapid translocation of estrogen receptor β, but not estrogen receptor α, to the neuronal plasma membrane. Neuroscience 153, 751-761 (2008)
26. A. Tremblay, G. B. Tremblay, F. Labrie, V. Giguère, Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol. Cell 3, 513-519 (1999)
27. K. D. Voigt, W. Bartsch, Intratissular androgens in benign prostatic hyperplasia and prostatic cancer. J. Steroid Biochem. 25, 749-757 (1986)
28. C. Zhao, H. Gao, Y. Liu, Z. Papoutsi, S. Jaffrey, J. A. Gustafsson, K. Dahlman-Wright, Genomewide mapping of estrogen receptor-β-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res. 70, 5174-5183 (2010)
29. T. H. Charn, E. T. Liu, E. C. Chang, Y. K. Lee, J. A. Katzenellenbogen, B. S. Katzenellenbogen, Genome-wide dynamics of chromatin binding of estrogen receptors α and β: Mutual restriction and competitive site selection. Mol. Endocrinol. 24, 47-59 (2010)
30. Y. K. Leung, Y. Gao, K. M. Lau, X. Zhang, S. M. Ho, ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-β/NFãB crosstalk. Neoplasia 8, 242-249 (2006)
31. Y. K. Leung, P. Mak, S. Hassan, S. M. Ho, Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 13162-13167 (2006)
32. P. Mak, Y. K. Leung, W. Y. Tang, C. Harwood, S. M. Ho, Apigenin suppresses cancer cell growth through ERβ. Neoplasia 8, 896-904 (2006)
33. F. Spyrakis, P. Cozzini, How computational methods try to disclose the estrogen receptor secrecy - modeling the flexibility. Curr. Med. Chem. 16, 2987-3027 (2009)